letter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessation

Jeng W.-J.Hsu Y.-C.TUNG-HUNG SUChen C.-H.2021-03-092021-03-0920190270-9139https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072994148&doi=10.1002%2fhep.30576&partnerID=40&md5=d16533663c25a34c99a8fd538394d04fhttps://scholars.lib.ntu.edu.tw/handle/123456789/551065[SDGs]SDG3entecavir; hepatitis B surface antigen; tenofovir; virus DNA; hepatitis B surface antigen; hepatitis B(e) antigen; antiviral therapy; drug withdrawal; hepatitis B; human; infection risk; Letter; limit of detection; priority journal; recurrence risk; relapse; chronic hepatitis B; Hepatitis B virus; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humansletter to the Editor: Deliberations More Than a Cut-off Hepatitis B Surface Antigen Value for Nucleos(t)ide Analogue Cessationletter10.1002/hep.30576307937712-s2.0-85072994148